Clinical trials for Bone sarcoma
36 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPHASE1, PHASE2NCT07479732Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic OsteosarcomaPeking University People's Hospital
- RECRUITINGPhase 1NCT07222735Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory SarcomasSt. Jude Children's Research Hospital · PI: Rebecca Epperly, MD
- RECRUITINGPhase 2NCT07359053MAGNATE-S: Paclitaxel Polymer Micelles Combo in Advanced SarcomaShanghai 6th People's Hospital
- RECRUITINGPhase 2NCT06939855QL1706 in the Treatment of Advanced Bone and Soft Tissue SarcomaSun Yat-sen University
- RECRUITINGNCT07215611Financial Toxicity in Patients With Resected Soft Tissue and Bone SarcomasM.D. Anderson Cancer Center · PI: Shalin S Patel, MD
- RECRUITINGNCT06958107LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma PatientsWake Forest University Health Sciences · PI: Johann Hsu, MD
- RECRUITINGPHASE1, PHASE2NCT07066982Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced SarcomasEssen Biotech
- RECRUITINGN/ANCT06796543Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone SarcomaSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · PI: Sahaja Acharya, MD
- RECRUITINGPHASE1, PHASE2NCT06709495Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory SarcomasDavid S Shulman, MD · PI: David Shulman, MD
- RECRUITINGNCT06409013Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With SarcomaMayo Clinic · PI: Matthew T. Houdek, M.D.
- RECRUITINGN/ANCT06129903Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With SarcomaMemorial Sloan Kettering Cancer Center · PI: Meredith Bartelstein, MD
- RECRUITINGPhase 2NCT06126510Clinical Study of VG161 in the Treatment of Advanced Bone and Soft Tissue SarcomaCNBG-Virogin Biotech (Shanghai) Ltd. · PI: Lu Xie, Medical PhD
- RECRUITINGPhase 2NCT06074692PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA)Ruijin Hospital · PI: Weibin Zhang, PhD, MD
- RECRUITINGPhase 2NCT05941325A Single-arm, Open-label, Single-center Prospective Study of Fruquintinib Combined With Envafolimab in the Treatment of Advanced or Unresectable Locally Advanced Bone and Soft Tissue SarcomaShanghai 6th People's Hospital
- RECRUITINGPHASE2, PHASE3NCT05691478A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed OsteosarcomaNational Cancer Institute (NCI) · PI: Michael W Bishop
- ACTIVE NOT RECRUITINGPhase 1NCT04616248In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid TumorsUniversity of Southern California · PI: Fumito Ito, MD
- RECRUITINGPhase 2NCT04515459Efficacy of Pre-operative Prehabilitation in Patients With Limb SarcomaInstitut Claudius Regaud
- RECRUITINGPhase 3NCT05235165Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With OsteosarcomaChildren's Oncology Group · PI: John J Doski
- ACTIVE NOT RECRUITINGPhase 2NCT04974008Osteosarcoma Maintenance Therapy With OST31-164Emerald Clinical Inc. · PI: Robert Petit, PhD
- RECRUITINGN/ANCT05051059Assessment of the Functional Outcome and Quality of Life in Sarcoma PatientsUniversitaire Ziekenhuizen KU Leuven · PI: Hazem Wafa
- RECRUITINGPhase 2NCT04698785Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas PatientsCentre Leon Berard · PI: Mehdi BRAHMI
- ACTIVE NOT RECRUITINGPhase 2NCT04417062Olaparib With Ceralasertib in Recurrent OsteosarcomaDana-Farber Cancer Institute · PI: Katherine Janeway, MD
- RECRUITINGPhase 2NCT04589741Toripalimab Combined With CAV/IE RegimenSun Yat-sen University · PI: Xing Zhang
- RECRUITINGPhase 2NCT04072042BIOmarker Driven Trial of VEGFR2 Inhibitor in Advanced or Metastatic SarcomaRuijin Hospital · PI: Weibin Zhang
- ACTIVE NOT RECRUITINGPhase 1NCT03628209Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable OsteosarcomaH. Lee Moffitt Cancer Center and Research Institute · PI: Patrick A. Thompson, MD
- RECRUITINGNCT05373810Registration Study SarcomaRadboud University Medical Center
- RECRUITINGNCT04758325The Sarcoma Biology and Outcome ProjectProf. Dr. Richard F Schlenk · PI: Richard F. Schlenk, Prof.Dr.med
- RECRUITINGNCT04181970Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORKGrupo Espanol de Investigacion en Sarcomas · PI: Javier MARTIN-BROTO, MD
- ACTIVE NOT RECRUITINGEarly Phase 1NCT03960177Glucarpidase After High-Dose Methotrexate in Patients With OsteosarcomaOHSU Knight Cancer Institute · PI: Christopher Ryan
- RECRUITINGNCT04122872GISAR German Interdisciplinary Sarcoma RegistryInstitut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest · PI: Salah-Eddin Al-Batran, Prof. Dr
- RECRUITINGPHASE1, PHASE2NCT03465592Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With SarcomaSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · PI: Nicolas Llosa, MD
- ENROLLING BY INVITATIONPhase 4NCT03244020LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic OncologyMassachusetts General Hospital · PI: Santiago A Lozano-Calderon, MD, PhD
- RECRUITINGNCT03261544Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?Duke University · PI: William Eward, MD, DVM
- ACTIVE NOT RECRUITINGPhase 2NCT02389244A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone SarcomasUNICANCER · PI: Florence DUFFAUD, MD PhD
- ACTIVE NOT RECRUITINGPhase 1NCT01590069Aerosolized Aldesleukin in Treating Patients With Lung MetastasesM.D. Anderson Cancer Center · PI: Najat Daw
- ACTIVE NOT RECRUITINGPhase 3NCT00470223Combined Chemotherapy With or Without Zoledronic Acid for Patients With OsteosarcomaUNICANCER · PI: Laurence Brugieres, MD